Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | QPCT | Q16769 | 2/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | BRD4 | O60885 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25334713 | 0.82 | ALDH1A1 (1.00) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL25335286 | 0.81 | ALDH1A1 (0.78) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL10833712 | 0.79 | ALDH1A1 (0.81) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL5827958 | 0.78 | MEN1 (0.59) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL12781709 | 0.78 | GAA (0.74) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL12767077 | 0.76 | ALDH1A1 (0.89) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL25937066 | 0.75 | ALDH1A1 (0.68) | ALDH1A1MAPTTSHRGAAQPCT | |
| SCHEMBL13655177 | 0.74 | SMN1; SMN2 (0.72) | ALDH1A1MAPTGAAQPCTLMNA | |
| SCHEMBL77178 | 0.74 | QPCT (1.00) | ALDH1A1GAAQPCTMAOBKMT2A | |
| SCHEMBL21637934 | 0.74 | MAPT (1.00) | ALDH1A1MAPTTSHRGAAQPCT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240960-A1 | COMPOSITIONS, FORMULATIONS, AND METHODS FOR SKIN TREATMENT | ODDITY LABS, LLC | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240960-A1 | COMPOSITIONS, FORMULATIONS, AND METHODS FOR SKIN TREATMENT | CUTA, COL14A1, DSG1 | ALDH1A1 3302/4885MAPT 404/4885TSHR 4386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.